← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2014Last known activity
Aug 12, 2025
Defunct as of Jan 31, 2021
Timeline
2010s
- Jun 1, 2012
Suzhou Connect Biopharmaceuticals— Founded
2020s
- Jan 31, 2021
Suzhou Connect Biopharmaceuticals— Defunct
Drugs by trial phase (4 distinct, 14 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (26)
- NCT06940154Lead sponsorPhase 2Aug 12, 2025
- NCT06940141Lead sponsorPhase 2Aug 8, 2025
- NCT05917782Lead sponsorPhase 1Jul 18, 2023
- NCT05917782Study directorPhase 1Jul 18, 2023
- NCT05905133Lead sponsorPhase 2Jul 15, 2023
- NCT05905133Study directorPhase 2Jul 15, 2023
- NCT05614817Lead sponsorPhase 3Dec 31, 2022
- NCT05614817Study directorPhase 3Dec 31, 2022
- NCT05040113Lead sponsorPhase 1Sep 4, 2021
- NCT05040113Study directorPhase 1Sep 4, 2021
- NCT05017480Study directorPhase 2Aug 31, 2021
- NCT05017480Lead sponsorPhase 2Aug 31, 2021
- NCT04783389Study directorPhase 2Jun 16, 2021
- NCT04783389Lead sponsorPhase 2Jun 16, 2021
- NCT04818229Lead sponsorPhase 1Jun 1, 2021
Details
- Founded
- Taicang, CN Jun 1, 2012
- Last known activity
- Aug 12, 2025
Notes
No evidence still extant